BeOne Medicines (ONC) Other Operating Expenses (2017 - 2023)

BeOne Medicines (ONC) has 7 years of Other Operating Expenses data on file, last reported at $188000.0 in Q2 2023.

• On a quarterly basis, Other Operating Expenses fell 99.74% year-over-year to $188000.0 in Q2 2023; TTM through Mar 2024 was $188000.0, a 100.29% increase from a year earlier, with the FY2020 full-year figure at $71.5 million, down 1.4% from the prior year.
• Other Operating Expenses for Q2 2023 stood at $188000.0, up from $187000.0 in the prior quarter.
• Over the last five years, Other Operating Expenses for ONC reached as high as $76.7 million in Q3 2022 and fell as low as -$213.5 million in Q4 2022.
• Historically, Other Operating Expenses has averaged $8.0 million across 5 years, with a median of $19.4 million in 2019.
• Across the five-year window, Other Operating Expenses jumped 229.08% in 2019 and sank 649.82% in 2021, its largest moves.
• Year by year, Other Operating Expenses stood at $18.3 million in 2019, then gained by 16.11% to $21.3 million in 2020, then sank by 649.82% to -$116.9 million in 2021, then plunged by 82.61% to -$213.5 million in 2022, then jumped by 100.09% to $188000.0 in 2023.
• Per Business Quant data, the three most recent Other Operating Expenses figures were $188000.0 in Q2 2023, $187000.0 in Q1 2023, and -$213.5 million in Q4 2022.